Found "Health Promotion": 1,004 results
Sort by
Relevance

Benjarin Santatiwongchai

Benjarin Santatiwongchai is Head of Communication for HITAP. Having studied BSc in Pharmacy from Mahidol University, her knowledge in current and emerging medical technologies and interventions has led her to become involved with Health Technology Assessment. In 2012, she completed her MSc in Health Economics at the University of York. She is now a

Siobhan Botwright

Siobhan has spent over 10 years working in public health at the national, regional, and global level, with experience across health technology assessment, market shaping, vaccine implementation, and capacity building in Asia, Africa, and the Americas. She has led studies employing a variety of methodologies, including system dynamics, qualitative c

Chayapat Rachatan

Chayapat Rachatan is currently a Project Associate at HITAP. She supports the HTA and health system research. Her research studies focus on COVID-19 policy research and decision support, effectiveness evaluation of COVID-19 vaccine chatbot, cost analysis of governance system in health sector, situational analysis of infectious disease modelling in

Saudamini Vishwanath Dabak

Saudamini Dabak is the Head of HITAP’s International Unit (HIU). She started working at HITAP as an Overseas Development Institute (ODI) Fellow in 2015. At HITAP, Saudamini has supported Health Technology Assessment (HTA) initiatives in Asia and Africa and has also been involved in conducting health systems research. Prior to working at HITAP, Saud

Tita Jongsomjit, PhD.

Tita Jongsomjit has been working as a Research Assistant at the Health Intervention and Technology Assessment Program (HITAP) Foundation since 2024. She holds a doctoral degree in Statistics from Thammasat University and is committed to applying her expertise and skills to conduct impactful research. Her primary area of interest is health technolog

Prototype Development for an Integrated Health Impact Assessment Framework

โรคเบาหวานและภาวะแทรกซ้อนของโรคเบาหวาน เป็นปัญหาสาธารณสุขที่สำคัญระดับโลก ผู้ป่วยเบาหวานทั่วโลกที่มีอายุระหว่าง 20 – 79 ปี ม
10 / Page